Epstein–Barr virus serology and PCR: conflicting results in an immunocompetent host. A case report and review of literature

References

• Bordon V, Padalko E, Benoit Y, Dhooge C, Laureys G. Incidence, kinetics and risk factors of Epstein–Barr virus viremia in pediatric patients after allogeneic stem cell transplantation. Pediatr Transplant. 2012;16(2):144–50.
   Web of Science ®Google Scholar
• Gulley ML. Molecular diagnosis of Epstein–Barr virus-related diseases. J Mol Diagn. 2001;3(1):1–10.
   Web of Science ®Google Scholar
• Hess RD. Routine Epstein–Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol. 2004;42(8):3381–7.
   Web of Science ®Google Scholar
• Okano M. Haematological associations of Epstein–Barr virus infection. Baillieres Best Pract Res Clin Haematol. 2000;13(2):199–214.
   Web of Science ®Google Scholar
• Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT. Epstein–Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev. 1988;1(3):300–12.
   Google Scholar
• Gulley ML, Tang W. Laboratory assays for Epstein–Barr virus-related disease. J Mol Diagn. 2008;10(4):279–92.
   Web of Science ®Google Scholar
• Kudo T, Egawa H, Kuzushima K, Kimura H, Morishima T, Ichiyama S. Diagnostic testing in Epstein–Barr virus infection. Clin Chem Lab Med. 2001;39(9):789–94.
   Web of Science ®Google Scholar
• Kimura H, Ito Y, Suzuki R, Nishiyama Y. Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol. 2008;18(5):305–19.
   Web of Science ®Google Scholar
• Ruf S, Wagner HJ. Determining EBV load: current best practice and future requirements. Expert Rev Clin Immunol. 2013;9(2):139–51.
   Web of Science ®Google Scholar
• Gulley ML, Tang W. Using Epstein–Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. Clin Microbiol Rev. 2010;23(2):350–66.
   Web of Science ®Google Scholar
• Gärtner B, Preiksaitis JK. EBV viral load detection in clinical virology. J Clin Virol. 2010;48(2):82–90.
   Web of Science ®Google Scholar
• Fan H, Gulley ML. Epstein–Barr viral load measurement as a marker of EBV-related disease. Mol Diagn. 2001;6(4):279–89.
   Google Scholar
• Gequelin LC, Riediger IN, Nakatani SM, Biondo AW, Bonfim CM. Epstein–Barr virus: general factors, virus-related diseases and measurement of viral load after transplant. Rev Bras Hematol Hemoter. 2011;33(5):383–8.
   Google Scholar
• Fryer JF, Heath AB, Wilkinson DE, Minor PD. Collaborative study to evaluate the proposed 1st WHO International Standard for Epstein–Barr virus (EBV) for nucleic acid amplification (NAT)-based assays. WHO ECBS Report 2011. Geneva: World Health Organization; 2011.
   Google Scholar
• Kullberg-Lindh C, Ascher H, Saalman R, Olausson M, Lindh M. Epstein–Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction. Pediatr Transplant. 2006;10(1):83–9.
   Web of Science ®Google Scholar
• Wadowsky RM, Laus S, Green M, Webber SA, Rowe D. Measurement of Epstein–Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR. J Clin Microbiol. 2003;41(11):5245–9.
   Web of Science ®Google Scholar
• Fafi-Kremer S, Brengel-Pesce K, Barguès G, Bourgeat MJ, Genoulaz O, Seigneurin JM, et al. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein–Barr virus load in whole blood, peripheral mononuclear cells and plasma. J Clin Virol. 2004;30(2):157–64.
   Web of Science ®Google Scholar
• Aalto SM, Juvonen E, Tarkkanen J, Volin L, Ruutu T, Mattila PS, et al. Lymphoproliferative disease after allogeneic stem cell transplantation — pre-emptive diagnosis by quantification of Epstein–Barr virus DNA in serum. J Clin Virol. 2003;28(3):275–83.
   Web of Science ®Google Scholar
• Wada K, Kubota N, Ito Y, Yagasaki H, Kato K, Yoshikawa T, et al. Simultaneous quantification of Epstein–Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol. 2007;45(5):1426–32.
   Web of Science ®Google Scholar
• Tsai DE, Douglas L, Andreadis C, Vogl DT, Arnoldi S, Kotloff R, et al. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial. Am J Transplant. 2008;8(5):1016–24.
   Web of Science ®Google Scholar
• Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K. Post-transplant lymphoproliferative disease and other Epstein–Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. Scand J Infect Dis. 2007;39(3):235–44.
   Web of Science ®Google Scholar
• Ishihara M, Tanaka E, Sato T, Chikamoto H, Hisano M, Akioka Y, et al. Epstein–Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients. Clin Nephrol. 2011;76(1):40–8.
   Web of Science ®Google Scholar
• Wagner HJ, Fischer L, Jabs WJ, Holbe M, Pethig K, Bucsky P. Longitudinal analysis of Epstein–Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction. Transplantation. 2002;74(5):656–64.
   Web of Science ®Google Scholar
• Wagner HJ, Wessel M, Jabs W, Smets F, Fischer L, Offner G, et al. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein–Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation. 2001;72(6):1012–9.
   Web of Science ®Google Scholar
• Stevens SJ, Pronk I, Middeldorp JM. Toward standardization of Epstein–Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol. 2001;39(4):1211–6.
   Web of Science ®Google Scholar
• Bakker NA, Verschuuren EA, Veeger NJ, van der Bij W, van Imhoff GW, Kallenberg CG, et al. Quantification of Epstein–Barr virus-DNA load in lung transplant recipients: a comparison of plasma versus whole blood. J Heart Lung Transplant. 2008;27(1):7–10.
   Web of Science ®Google Scholar
• Hakim H, Gibson C, Pan J, Srivastava K, Gu Z, Bankowski MJ, et al. Comparison of various blood compartments and reporting units for the detection and quantification of Epstein–Barr virus in peripheral blood. J Clin Microbiol. 2007;45(7):2151–5.
   Web of Science ®Google Scholar
• Kullberg-Lindh C, Olofsson S, Brune M, Lindh M. Comparison of serum and whole blood levels of cytomegalovirus and Epstein–Barr virus DNA. Transpl Infect Dis. 2008;10(5):308–15.
   Web of Science ®Google Scholar
• Rowe DT, Webber S, Schauer EM, Reyes J, Green M. Epstein–Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transpl Infect Dis. 2001;3(2):79–87.
   Google Scholar
• Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, et al. Epstein–Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Ann Hematol. 2006;85(7):478–84.
   Web of Science ®Google Scholar
• van Esser JW, Niesters HG, Thijsen SF, Meijer E, Osterhaus AD, Wolthers KC, et al. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein–Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol. 2001;113(3):814–21.
   Web of Science ®Google Scholar
• Limaye AP, Huang ML, Atienza EE, Ferrenberg JM, Corey L. Detection of Epstein–Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders. J Clin Microbiol. 1999;37(4):1113–6.
   Web of Science ®Google Scholar
• Preiksaitis JK, Pang XL, Fox JD, Fenton JM, Caliendo AM, Miller GG. Interlaboratory comparison of Epstein–Barr virus viral load assays. Am J Transplant. 2009;9(2):269–79.
   Web of Science ®Google Scholar
• Weinstock DM, Ambrossi GG, Brennan C, Kiehn TE, Jakubowski A. Preemptive diagnosis and treatment of Epstein–Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development. Bone Marrow Transplant. 2006;37(6):539–46.
   Web of Science ®Google Scholar
• Baldanti F, Gatti M, Furione M, Paolucci S, Tinelli C, Comoli P, et al. Kinetics of Epstein–Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation. J Clin Microbiol. 2008;46(11):3672–7.
   Web of Science ®Google Scholar